Fairmount Funds Management LLC Diversified Active

Location: West Conshohocken, PA

CIK: 0001802528 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 12, 2021

Total Value: $280M (100.0% shares, 0.0% debt)

Holdings (18)

INSM INSMED INC 11.5%

Value $32.02M Shares 961,797 Est. Cost $20.81 Unrealized +75.6%

FOLD AMICUS THERAPEUTICS INC 10.9%

Value $30.37M Shares 1,315,395 Est. Cost $9.80 Unrealized +108.7%

IOVA IOVANCE BIOTHERAPEUTICS INC 9.4%

Value $26.26M Shares 565,890 Est. Cost $24.87 Unrealized +59.7%

ACAD ACADIA PHARMACEUTICALS INC 8.6%

Value $24.07M Shares 450,317 Est. Cost $43.17 Unrealized +15.0%

— TRILLIUM THERAPEUTICS INC 7.8%

Value $21.74M Shares 1,478,181 Est. Cost $4.53 Unrealized —

— ALLAKOS INC 7.4%

Value $20.67M Shares 147,662 Est. Cost $81.12 Unrealized —

— ZOGENIX INC 7.0%

Value $19.6M Shares 980,645 Est. Cost $36.29 Unrealized —

AXSM AXSOME THERAPEUTICS INC 6.4%

Value $17.93M Shares 220,098 Est. Cost $80.87 Unrealized -7.5%

COGT COGENT BIOSCIENCES INC 6.3%

Value $17.51M Shares 1,558,975 Est. Cost $10.99 Unrealized 0.0%

ARGX ARGENX SE 5.3%

Value $14.69M Shares 49,950 Est. Cost $160.52 Unrealized —

— MIRATI THERAPEUTICS INC 4.8%

Value $13.29M Shares 60,500 Est. Cost $188.64 Unrealized —

— KARYOPHARM THERAPEUTICS INC 3.9%

Value $10.87M Shares 702,351 Est. Cost $18.82 Unrealized —

— GLOBAL BLOOD THERAPEUTICS IN 3.3%

Value $9.312M Shares 215,000 Est. Cost $43.31 Unrealized —

— AMARIN CORP PLC 2.6%

Value $7.375M Shares 1,508,237 Est. Cost $14.78 Unrealized —

ENTA ENANTA PHARMACEUTICALS INC 2.3%

Value $6.333M Shares 150,433 Est. Cost $61.59 Unrealized -28.6%

— SERES THERAPEUTICS INC 2.3%

Value $6.297M Shares 257,016 Est. Cost $24.50 Unrealized —

— VERONA PHARMA PLC 0.3%

Value $700K Shares 100,000 Est. Cost $6.24 Unrealized —

— MIRAGEN THERAPEUTICS INC 0.2%

Value $554K Shares 35,092 Est. Cost $15.79 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
INSM	INSMED INC	961,797	$32.02M	11.5%	$20.81	+75.6%	COM PAR $.01	457669307
FOLD	AMICUS THERAPEUTICS INC	1,315,395	$30.37M	10.9%	$9.80	+108.7%	COM	03152W109
IOVA	IOVANCE BIOTHERAPEUTICS INC	565,890	$26.26M	9.4%	$24.87	+59.7%	COM	462260100
ACAD	ACADIA PHARMACEUTICALS INC	450,317	$24.07M	8.6%	$43.17	+15.0%	COM	004225108
—	TRILLIUM THERAPEUTICS INC	1,478,181	$21.74M	7.8%	$4.53	—	COM NEW	89620X506
—	ALLAKOS INC	147,662	$20.67M	7.4%	$81.12	—	COM	01671P100
—	ZOGENIX INC	980,645	$19.6M	7.0%	$36.29	—	COM NEW	98978L204
AXSM	AXSOME THERAPEUTICS INC	220,098	$17.93M	6.4%	$80.87	-7.5%	COM	05464T104
COGT	COGENT BIOSCIENCES INC	1,558,975	$17.51M	6.3%	$10.99	0.0%	COM	19240Q201
ARGX	ARGENX SE	49,950	$14.69M	5.3%	$160.52	—	SPONSORED ADR	04016X101
—	MIRATI THERAPEUTICS INC	60,500	$13.29M	4.8%	$188.64	—	COM	60468T105
—	KARYOPHARM THERAPEUTICS INC	702,351	$10.87M	3.9%	$18.82	—	COM	48576U106
—	GLOBAL BLOOD THERAPEUTICS IN	215,000	$9.312M	3.3%	$43.31	—	COM	37890U108
—	AMARIN CORP PLC	1,508,237	$7.375M	2.6%	$14.78	—	SPONS ADR NEW	023111206
ENTA	ENANTA PHARMACEUTICALS INC	150,433	$6.333M	2.3%	$61.59	-28.6%	COM	29251M106
—	SERES THERAPEUTICS INC	257,016	$6.297M	2.3%	$24.50	—	COM	81750R102
—	VERONA PHARMA PLC	100,000	$700K	0.3%	$6.24	—	SPONSORED ADS	925050106
—	MIRAGEN THERAPEUTICS INC	35,092	$554K	0.2%	$15.79	—	COM NEW	60463E202